Faruqi & Faruqi, LLP, a leading national securities firm headquartered
in New York City, is investigating the Board of Directors of Parlux
Fragrances Inc. ("Parlux” or the "Company”) (NASDAQ: PARL) for potential
breaches of fiduciary duties in connection with their conduct related to
the sale of the Company to Perfumania Holdings, Inc. ("Perfumania”)
(NASDAQ: PERF) in a cash and stock deal valued at about $174.62 million.
Under the terms of the proposed transaction, Parlux stockholders can
choose to take either (a) $4.00 in cash and 0.20 share of Perfumania, or
(b) 0.53333 of a share of the acquirer. The deal values Parlux at $6.65
to $7.06 per share, based on Perfumania’s $13.23 closing price on
December 27, 2011.
Request more information now by clicking here: www.faruqilaw.com/PARL.
Whether Parlux’s Board of Directors breached their fiduciary duties to
the Company’s stockholders by failing to conduct an adequate and fair
sales process prior to agreeing to this proposed transaction, whether
the proposed transaction undervalues Parlux’s shares and by how much
this proposed transaction undervalues the Company to the detriment of
Parlux’s shareholders are the key focus of this investigation.
Faruqi & Faruqi, LLP is a national law firm which represents investors
and individuals in class action litigation. The firm is focused on
providing exemplary legal services in complex litigation in the areas of
securities, shareholder, antitrust and consumer litigation, throughout
all phases of litigation. The firm has an experienced trial team which
has achieved significant victories on behalf of the firm’s clients.
If you own common stock in Parlux and wish to obtain additional
information, please visit us at www.faruqilaw.com/PARL
or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@faruqilaw.com
or by telephone at (877) 247-4292 or (212) 983-9330.
Attorney Advertising. (C) 2011 Faruqi & Faruqi, LLP. The law firm
responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com).
Prior results do not guarantee or predict a similar outcome with respect
to any future matter. We are happy to discuss your particular case.
